Back to ESRX Stock Lookup

ESRX Related Analyst Comments

Apr 12, 2013 11:48 AM UBS Adjusts Numbers on Express Scripts (ESRX)

Mar 27, 2013 11:57 AM Express Scripts (ESRX) Pricing Aggressively, Leerink Swann Maintains Buy

Mar 12, 2013 08:37 AM Goldman Sachs Downgrades CVS Caremark (CVS) to Neutral, Few Catalysts

Dec 31, 2012 12:13 PM VIVUS (VVUS) Qsymia Sales Lag Investor Sentiment in Nov.; Many Expect Better FY13

Dec 24, 2012 10:36 AM Express Scripts (ESRX) Deal is Huge Win for VIVUS (VVUS); Qsymia Reimbursement Will Improve

Dec 19, 2012 09:46 AM Sell Catamaran (CTRX) Ahead of HealthSpring Contract Update - Cramer

Dec 14, 2012 09:25 AM CVS (CVS) Taking Walgreen (WAG) Share - Analyst

Oct 22, 2012 10:08 AM VIVUS (VVUS) Qsymia Prescriptions Keep Chugging, Gain 27%+ Last Week

Oct 16, 2012 01:23 PM Buckle-Up Ahead of Elections as Health Care Stocks Take a Ride

Sep 6, 2012 03:19 PM Leerink Swann on Pharmacy Benefit Managers: TRICARE Excludes Walgreen (WAG) from Network, Positive for Express Scripts (ESRX)

Sep 6, 2012 07:24 AM Jefferies Maintains a 'Hold' on Walgreen (WAG); Goodbye TRICARE

Sep 6, 2012 07:23 AM Jefferies Reiterates a 'Buy' on Express Scripts (ESRX); On Track With Narrow Network Strategy

Aug 23, 2012 07:34 AM Jefferies Reiterates a 'Buy' on Express Scripts (ESRX); Still Bullish

Aug 20, 2012 12:12 PM LabCorp (LH) Could See a Hit from Aetna/Coventry Health Deal

Aug 20, 2012 08:24 AM CVS Caremark (CVS) Will Come Out A Winner in Aetna/Coventry Deal

Aug 1, 2012 07:17 AM Jefferies Maintains a 'Hold' on Walgreen (WAG); Key Takeaways From NYC Meeting w/ Mgmt

Jul 6, 2012 08:25 AM Goldman Sachs Maintains a 'Neutral' on Rite-Aid (RAD); Same-Store Sales Reflect Impact of Generics

Jun 22, 2012 01:10 PM Morgan Stanley Says Express Scripts (ESRX) Customers Becoming Cozy with Rite Aid (RAD)

Jun 8, 2012 10:25 AM UBS Reiterates a 'Neutral' on Rite-Aid (RAD); A Few Longer-Term Tailwinds, But Staying Sidelined For Now

May 3, 2012 10:57 AM UBS Raises Numbers on CVS Caremark (CVS); Comments From Conference Call

Apr 19, 2012 01:37 PM UBS on Healthcare Distribution - PBMs: Implications from SXCI/CHSI Deal

Apr 4, 2012 10:53 AM Jefferies Reiterates a 'Buy' on Express Scripts (ESRX); Real Boost From MHS Acquisition

Mar 28, 2012 12:11 PM UBS Maintains a 'Buy' on Walgreen (WAG); Downside Risk Priced In, Creating Favorable Risk/Reward Balance

Mar 13, 2012 09:11 AM Jefferies Reiterates a 'Buy' on Express Scripts (ESRX); FTC Review Extension Was Expected; Closing Target Specificity A Bullish Sign

Feb 23, 2012 10:44 AM Jefferies Maintains a 'Buy' on Express Scripts (ESRX); Incurs High Q4 Expenses As Its Preps For MHS Integration

Feb 9, 2012 02:36 PM UBS Maintains a 'Buy' on CVS Caremark (CVS); Raising FY12/13 EPS Estimates

Feb 2, 2012 12:15 PM UBS Maintains a 'Neutral' on Rite-Aid (RAD); Expect Accelerated EBITDA in Calendar ‘12

Feb 1, 2012 01:01 PM UBS Maintains a 'Buy' on Walgreen (WAG); January Comps Will Represent First Month Without ESRX

Jan 13, 2012 12:06 PM UBS Maintains a 'Buy' on Express Scripts (ESRX); Raising Estimates for Medco Merger

Jan 13, 2012 12:03 PM UBS Maintains a 'Neutral' on CVS Caremark (CVS); Raising ‘13 EPS for Generics/PBM Mojo

Jan 13, 2012 11:57 AM UBS Maintains a 'Buy' on AmerisourceBergen (ABC); Lower F2013-14 EPS For Generics + Medco

Dec 19, 2011 02:33 PM Barclays Maintains an 'Overweight' on Express Scripts (ESRX); Supply Chain Exec Dismissal to Alter WAG Settlement Chances?

Dec 16, 2011 03:30 PM Barclays maintains an 'Underweight' on Walgreen (WAG); 1Q12 Earnings Preview

Dec 14, 2011 12:02 PM Oppenheimer Maintains an 'Outperform' on Express Scripts (ESRX); WellPoint Dispute Likely Overblown

Nov 4, 2011 01:01 PM UBS Maintains a 'Buy' on CVS Caremark (CVS); Post-Call: Plenty of Positive Datapoints

Nov 4, 2011 09:29 AM Jefferies Raises Price Target on CVS Caremark (CVS), Sees Upside Potential

Oct 24, 2011 10:39 AM Citi Says Buy CVS (CVS) Ahead of Q3 Results as Walgreen/Express Scripts Talks Ongoing

Oct 7, 2011 09:08 AM Leerink Swann Reiterates an 'Outperform' on Express Scripts (ESRX); Overhang Removed; We Are Aggressive Buyers

Oct 6, 2011 03:47 PM Deutsche Cuts Price Target on Express Scripts (ESRX) Following New Guidance

Oct 6, 2011 11:04 AM UBS Maintains a 'Buy' on Walgreen (WAG); Lowering EPS Estimates; Still Assume ESRX Resolution in Published Estimates

Oct 4, 2011 01:13 PM Barclays Maintains an 'Underweight' on Walgreen (WAG); September Sales Preview

Sep 28, 2011 12:57 PM Barclays Maintains an 'Underweight' on Walgreen (WAG); Current Earnings Don't Matter

Sep 28, 2011 08:44 AM Jefferies Cuts Price Target on Walgreen (WAG), Encourges a Settlement with Express Scripts (ESRX)

Sep 26, 2011 03:23 PM Q4 Preview: Walgreen (WAG) Investors Looking for Express Scripts, Generic Drug Updates

Sep 21, 2011 01:44 PM Barclays Maintains an 'Underweight' on Walgreen (WAG); 4Q11 Earnings Preview

Sep 21, 2011 09:11 AM Jefferies Cuts Price Target on Express Scripts (ESRX), No More Buyback and Weak Volumes

Sep 12, 2011 01:29 PM Barclays Maintains an 'Underweight' on Walgreen (WAG); Express Scripts' (ESRX) Suit Could Slow Resolution

Sep 12, 2011 11:25 AM Jefferies Comments on Express Scripts (ESRX), Great Long-Term Pick for Investors

Sep 2, 2011 07:09 AM Leerink Swann Maintains an 'Outperform' on Express Scripts (ESRX); Merger Timing, Script Trends, Walgreen and Valuation

Aug 3, 2011 03:26 PM Q2 Preview: CVS (CVS) Looking to PBM to Continue Strong Results

Back to ESRX Stock Lookup